YUNHONG CTI LTD (CTIB)
US98873Q1004 - Common Stock
We assign a fundamental rating of 1 out of 10 to CTIB. CTIB was compared to 68 industry peers in the Household Durables industry. CTIB may be in some trouble as it scores bad on both profitability and health. CTIB is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CTIB had negative earnings in the past year.
In the past year CTIB had a positive cash flow from operations.
In the past 5 years CTIB always reported negative net income.
In multiple years CTIB reported negative operating cash flow during the last 5 years.
1.2 Ratios
CTIB has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CTIB's Gross Margin of 17.33% is on the low side compared to the rest of the industry. CTIB is outperformed by 92.54% of its industry peers.
In the last couple of years the Gross Margin of CTIB has declined.
The Profit Margin and Operating Margin are not available for CTIB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.33% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.6%
GM growth 5Y-6.59%
2. Health
2.1 Basic Checks
CTIB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CTIB has more shares outstanding
Compared to 5 years ago, CTIB has more shares outstanding
Compared to 1 year ago, CTIB has an improved debt to assets ratio.
2.2 Solvency
CTIB has an Altman-Z score of 1.38. This is a bad value and indicates that CTIB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.38, CTIB is doing worse than 79.10% of the companies in the same industry.
CTIB has a debt to FCF ratio of 11.30. This is a negative value and a sign of low solvency as CTIB would need 11.30 years to pay back of all of its debts.
With a Debt to FCF ratio value of 11.30, CTIB is not doing good in the industry: 67.16% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.10 is on the high side and indicates that CTIB has dependencies on debt financing.
CTIB has a Debt to Equity ratio of 1.10. This is in the lower half of the industry: CTIB underperforms 77.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 11.3 | ||
| Altman-Z | 1.38 |
ROIC/WACCN/A
WACC9.25%
2.3 Liquidity
A Current Ratio of 1.29 indicates that CTIB should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.29, CTIB is doing worse than 88.06% of the companies in the same industry.
CTIB has a Quick Ratio of 1.29. This is a bad value and indicates that CTIB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.41, CTIB is not doing good in the industry: 94.03% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 0.41 |
3. Growth
3.1 Past
CTIB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.62%, which is quite impressive.
The Revenue for CTIB has decreased by -17.59% in the past year. This is quite bad
CTIB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.33% yearly.
EPS 1Y (TTM)94.62%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q90%
Revenue 1Y (TTM)-17.59%
Revenue growth 3Y-17.61%
Revenue growth 5Y-20.33%
Revenue growth Q2Q-8.13%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
CTIB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, CTIB is valued a bit more expensive than the industry average as 68.66% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 89.15 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CTIB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
YUNHONG CTI LTD
NASDAQ:CTIB (9/22/2023, 7:00:01 PM)
After market: 2.36 -0.04 (-1.67%)2.4
+0.43 (+21.83%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap48.23M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.33% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.29 | ||
| Quick Ratio | 0.41 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)94.62%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-17.59%
Revenue growth 3Y-17.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y